Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial).,Journal of Gynecologic Oncology

当前位置： X-MOL 学术 › J. Gynecol. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial).
Journal of Gynecologic Oncology ( IF 3.4 ) Pub Date : 2021-6-5 , DOI: 10.3802/jgo.2021.32.e60
Jun Guan _{1,

2} , Yu Xue ₃ , Rong Yu Zang ₄ , Ji Hong Liu ₅ , Jian Qing Zhu ₆ , Ying Zheng ₇ , Bo Wang ₁ , Hua Ying Wang ₈ , Xiao Jun Chen _{1,

2}

Affiliation

Sentinel lymph node (SLN) mapping has been recommended as an alternative staging approach to lymphadenectomy for apparent uterine-confined endometrial cancer (EC). However, the prognostic value of SLN mapping alone instead of systematic lymphadenectomy on EC patients remains unclear.

中文翻译：

前哨淋巴结定位与系统盆腔淋巴结切除术对术前局限于子宫的中高危子宫内膜癌患者预后的影响：非劣效性随机对照试验（SNEC 试验）的试验方案。

前哨淋巴结 (SLN) 标测已被推荐作为淋巴结切除术的替代分期方法，用于治疗明显的子宫局限型子宫内膜癌 (EC)。然而，单独 SLN 定位而不是系统性淋巴结切除术对 EC 患者的预后价值仍不清楚。

更新日期：2021-06-06

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11